|
Hypertrophy
Citations 341-350 of 685 total displayed.
|
Past content
(since Mar 1999):
|
- Scientific Contributions
Targeted Deletion of Matrix Metalloproteinase 2 Ameliorates Myocardial Remodeling in Mice With Chronic Pressure Overload
- Hidenori Matsusaka, Tomomi Ide, Shouji Matsushima, Masaki Ikeuchi, Toru Kubota, Kenji Sunagawa, Shintaro Kinugawa, and Hiroyuki Tsutsui
Hypertension published February 27, 2006, doi:10.1161/01.HYP.0000208840.30778.00
[Abstract]
- Editorial Commentary
Matrix Reloaded. The Matrix Metalloproteinase Paradox
- Anna N. Panek and Michael Bader
Hypertension published February 27, 2006, doi:10.1161/01.HYP.0000208603.97395.44
[Abstract]
- Scientific Contributions
Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II
- Koichi Yamamoto, Mitsuru Ohishi, Tomohiro Katsuya, Norihisa Ito, Masashi Ikushima, Masaharu Kaibe, Yuji Tatara, Atsushi Shiota, Sumio Sugano, Satoshi Takeda, Hiromi Rakugi, and Toshio Ogihara
Hypertension published February 27, 2006, doi:10.1161/01.HYP.0000205833.89478.5b
[Abstract]
- Scientific Contributions
Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats
- Kohzo Nagata, Koji Obata, Jinglan Xu, Sahoko Ichihara, Akiko Noda, Hirotaka Kimata, Tomoko Kato, Hideo Izawa, Toyoaki Murohara, and Mitsuhiro Yokota
Hypertension published February 27, 2006, doi:10.1161/01.HYP.0000203772.78696.67
[Abstract]
- Editorial Commentaries
Prognostic Relevance of Blood Pressure Variability
- Gianfranco Parati and Mariaconsuelo Valentini
Hypertension 2006;47:137-138; published online before print as doi:10.1161/01.HYP.0000198542.51471.c4
[Full text]
- Editorial Commentaries
Caution for Winter Morning Surge in Blood Pressure: A Possible Link With Cardiovascular Risk in the Elderly
- Kazuomi Kario
Hypertension 2006;47:139-140; published online before print as doi:10.1161/01.HYP.0000199162.89857.7a
[Full text]
- Editorial Commentaries
Pressure, Waves, and Kidney Outcomes in Kidney Transplant Donors and Recipients
- Robert D. Toto
Hypertension 2006;47:141-142; published online before print as doi:10.1161/01.HYP.0000201235.90035.6c
[Full text]
- Original Articles
Uric Acid, Left Ventricular Mass Index, and Risk of Cardiovascular Disease in Essential Hypertension
- Yoshio Iwashima, Takeshi Horio, Kei Kamide, Hiromi Rakugi, Toshio Ogihara, and Yuhei Kawano
Hypertension 2006;47:195-202; published online before print as doi:10.1161/01.HYP.0000200033.14574.14
[Abstract]
[Full text]
- Scientific Contributions
Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy
- David J. Kennedy, Sandeep Vetteth, Sankaridrug M. Periyasamy, Mohamed Kanj, Larisa Fedorova, Samer Khouri, M. Bashar Kahaleh, Zijian Xie, Deepak Malhotra, Nikolai I. Kolodkin, Edward G. Lakatta, Olga V. Fedorova, Alexei Y. Bagrov, and Joseph I. Shapiro
Hypertension published January 30, 2006, doi:10.1161/01.HYP.0000202594.82271.92
[Abstract]
- Editorial Commentary
Growth Factor Receptor Transactivation in Mediating End Organ Damage by Angiotensin II
- Hiroyuki Suzuki and Satoru Eguchi
Hypertension published January 23, 2006, doi:10.1161/01.HYP.0000202497.83294.50
[Abstract]
|
|
